脂肪性肝疾患(Fatty Liver Disease)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Fatty Liver Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Fatty Liver Disease 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Fatty Liver Disease 33
Feb 24, 2015: Galectin Therapeutics Announces Details of the Design of Its Phase 2 Program With GR-MD-02 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Galmed International Ltd. 36
Clinical Trial Overview of Galmed International Ltd. 36
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
DURECT Corporation 38
Clinical Trial Overview of DURECT Corporation 38
PharmaKing Co., Ltd. 39
Clinical Trial Overview of PharmaKing Co., Ltd. 39
Novo A/S 40
Clinical Trial Overview of Novo A/S 40
Merck & Co., Inc. 41
Clinical Trial Overview of Merck & Co., Inc. 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Abbott Laboratories 43
Clinical Trial Overview of Abbott Laboratories 43
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Clinical Trial Overview of Top Institutes / Government 45
Tabriz University of Medical Sciences 45
Clinical Trial Overview of Tabriz University of Medical Sciences 45
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
Tehran University of Medical Sciences 47
Clinical Trial Overview of Tehran University of Medical Sciences 47
FUDAN University 48
Clinical Trial Overview of FUDAN University 48
University of Michigan 49
Clinical Trial Overview of University of Michigan 49
Ahvaz Jundishapur University of Medical Sciences 50
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 50
Bambino Gesu Hospital and Research Institute 51
Clinical Trial Overview of Bambino Gesu Hospital and Research Institute 51
Third Military Medical University 52
Clinical Trial Overview of Third Military Medical University 52
Chinese University of Hong Kong 53
Clinical Trial Overview of Chinese University of Hong Kong 53
Hadassah Medical Organization 54
Clinical Trial Overview of Hadassah Medical Organization 54
Five Key Clinical Profiles 55
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82